KR7085660009
KR7085660009
CHA Biotech
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 762.38B EUR | 1.01T EUR | 1.75T EUR | 1.36T EUR |
Enterprise Value | 1.82T EUR | 1.52T EUR | 2.36T EUR | 2.03T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 70.42x | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 0.58x | 0.77x | 1.35x | 1.41x |
Price to Book | -- | 2.42x | 3.4x | 4.48x |
EV/Revenue | 1.39x | 1.16x | 1.82x | 2.11x |
EV/EBITDA | -72.04x | 14.91x | 105.43x | 3,004.92x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -32.52% | -28.66% | -16.64% | -12.68% |